| Bioactivity | LRRK2/NUAK1/TYK2-IN-1 (conpound 226) shows inhibitory activity toward LRRK2 (Wt), LRRK2 (G2019), TYK2 and NUAK1, with IC50 values lower than 10 nM. LRRK2/NUAK1/TYK2-IN-1 can be used for autoimmune disease research[1]. |
| Name | LRRK2/NUAK1/TYK2-IN-1 |
| CAS | 2629192-96-5 |
| Formula | C20H11F3N6 |
| Molar Mass | 392.34 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Roland Koestler, et al. 1,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compounds as lrrk2, nuak1 and/or tyk2 kinase modulators for the treatment of e.g. autoimmune disease. Patent WO2021048618A1. |
LRRK2/NUAK1/TYK2-IN-1
CAS: 2629192-96-5 F: C20H11F3N6 W: 392.34
LRRK2/NUAK1/TYK2-IN-1 (conpound 226) shows inhibitory activity toward LRRK2 (Wt), LRRK2 (G2019), TYK2 and NUAK1, with IC
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.